Women with a good recovery after stroke and a moderate level of optimism had a 0.40‐fold reduction in the odds of developing new-onset poststroke depression.
Atypical antipsychotic adjunctive therapy and mood stabilizers may be a more effective treatment than mood stabilizer monotherapy.
Researchers measured vital status records to ascertain death from 16 site-specific malignancies.
Lithium has been the mainstay of treatment for decades, but several other classes of medication have recently been used with varying degrees of success.
The declining rates for lithium use are linked to the burden of side effects and toxicity associated with the drug.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
Some aspects of depression literacy were lower among patients with depression.
Comorbid panic disorder was linked to increased likelihood of side effects during treatment for depression.
About one-third of patients with MCI are also diagnosed with depression.
The Mood Zoom questionnaire rates anxiety, elation, sadness, anger, irritability, and energy on a 7-point scale.
The researchers found that the prevalence of anxiety was 21.3% and depression 27.2% in patients with HH.
The transition to standard time is likely to be associated with a negative psychological effect.
Cognitive reserve in bipolar patients gives a possible explanation for the differences seen among patients in their ability to perform in neurocognitive tests.
Patients taking memantine plus sertraline had significantly greater improvement and greater response rate.
Therapeutic drug monitoring and pharmacogenetic analyses may be useful in the optimization of clomipramine in nonresponders.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
Researchers observe a cohort effect for earlier age at onset of bipolar disorder. Bipolar disorder is also more common in patients with a family history of unipolar depression and bipolar disorder.
Treatment initiated in the early stages of bipolar disorder is more effective than treatment in later stages.
Survey results revealed that only 28.7% of patients with depression receive any treatment.
The number needed to treat was 5.9 for sertraline vs placebo to prevent depression after a traumatic brain injury.
Children exposed to acetaminophen prenatally had an increased risk of multiple behavioral difficulties.
Older adults with depression are less likely to adhere to COPD maintenance medications regimens.
While many suicide prevention techniques are effective, others have not been proven to be beneficial.
For children and teens diagnosed with depression, the benefits of the most commonly prescribed antidepressants may not outweigh the risks.
In adolescents with type 1 or type 2 diabetes, the rates of diagnosed depression are lower than the number of patients reporting depressive symptoms.
An analysis of 55 studies found that medical literature overestimates the efficacy of psychotherapy for depression by about 10%.
People who started taking an antidepressant while taking NSAIDs had increased risk of intracranial hemorrhage.
Rexulti is indicated for treating schizophrenia and for major depression after first-line treatments fail.
Geriatric patients who are not responding well to antidepressants may benefit from a combination of pharmacotherapy and psychotherapy.